These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2943142)

  • 1. The renin system and atrial natriuretic hormone in congestive heart failure.
    Laragh JH; Cody RJ; Covit AB; Atlas SA
    Acta Med Scand Suppl; 1986; 707():45-53. PubMed ID: 2943142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone.
    Laragh JH
    Drugs; 1986; 32 Suppl 5():1-12. PubMed ID: 2952486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conceptual and therapeutic approaches to inhibition of the renin-angiotensin system in chronic heart failure.
    Cody RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S58-65. PubMed ID: 2422494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure.
    Riegger AJ
    Eur Heart J; 1990 Apr; 11 Suppl B():79-83. PubMed ID: 2142083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats.
    Lappe RW; Todt JA; Wendt RL
    Circ Res; 1987 Jul; 61(1):134-40. PubMed ID: 3038365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-mediated vasoconstriction in chronic congestive heart failure, and response to converting enzyme inhibition.
    Cody RJ
    Am J Med; 1984 Aug; 77(2A):71-7. PubMed ID: 6089559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.
    Kramer HJ; Lichardus B
    Klin Wochenschr; 1986 Aug; 64(16):719-31. PubMed ID: 2945041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M
    Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
    J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.
    Holmer SR; Riegger AJ; Notheis WF; Kromer EP; Kochsiek K
    Basic Res Cardiol; 1987; 82(2):101-8. PubMed ID: 2955780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.
    Laragh JH
    N Engl J Med; 1985 Nov; 313(21):1330-40. PubMed ID: 2932646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic hormone: a regulator of blood pressure and volume homeostasis.
    Laragh JH; Atlas SA
    Kidney Int Suppl; 1988 Sep; 25():S64-71. PubMed ID: 2972865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 and the renal renin-angiotensin system.
    Harris RC; Zhang MZ; Cheng HF
    Acta Physiol Scand; 2004 Aug; 181(4):543-7. PubMed ID: 15283769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH; Resnick LM
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.